Research & development > Life sciences

Skin cancer costs 30 times more to treat than prevent

03 July, 2017

Despite being largely preventable, skin cancer costs Victoria's public hospitals more than $50 million a year, new research from Deakin University and Cancer Council Victoria has found.


Aus cancer vaccine closer to human trials

30 June, 2017

Radvax, a cancer treatment vaccine, being developed by South Australian company Vaxine, is closer to human trials.


New approach examines how medicines act on cells

19 June, 2017

Australian researchers have developed a new approach to monitor how medicines interact with and modify the activity of living cells.


'Turning off' allergies

05 June, 2017 by Adam Florance

Researchers are one step closer to a treatment that could 'turn off' the immune response that causes common allergies, including asthma — which affects over two million Australians.


Staying clinically competitive

05 June, 2017 by Mansi Gandhi

Cost-competitiveness, high-quality data and fast study start-up times are some of the key factors that make Australia an attractive market for clinical trials. But as other countries strive to improve their clinical competitiveness, can Australia hold a dominant position?


Designer viruses to fight cancer

29 May, 2017

Scientists have created designer viruses that alert the immune system and cause it to send killer cells to help fight cancer.


Putting brakes on cancer's ability to spread

29 May, 2017 by Phil Sneiderman

US researchers have discovered a biochemical signalling process that causes densely packed cancer cells to break away from a tumour and spread the disease elsewhere in the body.


Australian researchers build brain-on-a-chip

15 May, 2017

Australian researchers have grown brain cells on a semiconductor wafer patterned with nanowires which act as a scaffold to guide the growth of brain cells.


Jumping without slipping: the secret of the leafhopper

12 May, 2017

UK researchers have uncovered the secret behind the explosive leaping ability of leafhopper insects — a discovery that could help create better technology in the future.


Cannabis could reverse brain decline

10 May, 2017

Cannabis has the potential to reverse brain ageing and improve memory function, a new European study has revealed.


Major cancer protein conundrum solved

08 May, 2017

US scientists have solved a major conundrum regarding the exact role of a protein in a critical cancer-linked pathway.


Researchers rewire stem cells to fight arthritis

01 May, 2017 by Jim Dryden

US researchers have rewired mouse stem cells' genetic circuits to produce an anti-inflammatory arthritis drug when the cells encounter inflammation. The technique eventually could act as a vaccine for arthritis and other chronic conditions.


PreveCeutical and UniQuest partner to develop CBD sol-gels

01 May, 2017

PreveCeutical Medical and UniQuest have partnered to develop a soluble gel to deliver cannabinoids directly to the brain via the nasal cavity.


Fungi — a goldmine for pharmaceuticals?

21 April, 2017 by Chalmers University of Technology

Researchers at Chalmers University of Technology have developed a method for finding new antibiotics from fungi.


R&D Tax Incentive cap to hamper commercialisation, industry says

19 April, 2017

Australian biotech and medical associations have come together to urge the government to "not devastate" the Australian MTP (medtech, biotech and pharmaceutical) sector "by gutting the Research & Development (R&D) Tax Incentive".


  • All content Copyright © 2021 Westwick-Farrow Pty Ltd